NO920852L - Midler for diagnostisering av demyelinisante neuropatier,saerlig multippel sklerose - Google Patents

Midler for diagnostisering av demyelinisante neuropatier,saerlig multippel sklerose

Info

Publication number
NO920852L
NO920852L NO92920852A NO920852A NO920852L NO 920852 L NO920852 L NO 920852L NO 92920852 A NO92920852 A NO 92920852A NO 920852 A NO920852 A NO 920852A NO 920852 L NO920852 L NO 920852L
Authority
NO
Norway
Prior art keywords
multiple sclerosis
neuropatias
diagnostizing
demyelinisant
measures
Prior art date
Application number
NO92920852A
Other languages
English (en)
Norwegian (no)
Other versions
NO920852D0 (no
Inventor
Jean-Pierre Zanetta
Jean-Marie Warter
Sabine Kuechler
Guy Vincendon
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Publication of NO920852L publication Critical patent/NO920852L/no
Publication of NO920852D0 publication Critical patent/NO920852D0/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/827—Lectins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/828—Protein A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Air Bags (AREA)
  • Steering-Linkage Mechanisms And Four-Wheel Steering (AREA)
  • Valve Device For Special Equipments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fuses (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Ignition Installations For Internal Combustion Engines (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO920852A 1989-09-06 1992-03-04 Midler for diagnostisering av demyelinisante neuropatier,saerlig multippel sklerose NO920852D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8911667A FR2651581B1 (fr) 1989-09-06 1989-09-06 Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques.
PCT/FR1990/000638 WO1991003737A1 (fr) 1989-09-06 1990-08-30 Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques

Publications (2)

Publication Number Publication Date
NO920852L true NO920852L (no) 1992-03-04
NO920852D0 NO920852D0 (no) 1992-03-04

Family

ID=9385190

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920852A NO920852D0 (no) 1989-09-06 1992-03-04 Midler for diagnostisering av demyelinisante neuropatier,saerlig multippel sklerose

Country Status (14)

Country Link
US (1) US5225352A (de)
EP (1) EP0416984B1 (de)
JP (1) JP3032290B2 (de)
AT (1) ATE90791T1 (de)
AU (1) AU648516B2 (de)
CA (1) CA2024731A1 (de)
DE (1) DE69001972T2 (de)
DK (1) DK0416984T3 (de)
ES (1) ES2057476T3 (de)
FI (1) FI921009A0 (de)
FR (1) FR2651581B1 (de)
IE (1) IE64042B1 (de)
NO (1) NO920852D0 (de)
WO (1) WO1991003737A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679034A1 (fr) * 1991-07-10 1993-01-15 Centre Nat Rech Scient Determination de la malignite des cellules de tumeurs humaines ou animales, au moyen de lectines endogenes.
FR2689520B1 (fr) 1992-04-03 1996-07-19 Bio Merieux Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques.
FR2689521B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture.
ES2233936T3 (es) * 1994-02-04 2005-06-16 Bio Merieux Virus msrv1 asociado a la esclerosis en placas, sus constituyentes nucleicos y sus aplicaciones.
FR2716198B1 (fr) * 1994-02-15 1996-04-19 Bio Merieux Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
FR2737500B1 (fr) 1995-08-03 1997-08-29 Bio Merieux Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques
ATE440141T1 (de) 1996-11-26 2009-09-15 Bio Merieux Virales material und mit multipler sklerose assoziierte nukleotidfragmente mit diagnostischen,prophylaktischen und therapeutischen verwendungen
JPH11143616A (ja) 1997-11-10 1999-05-28 Sega Enterp Ltd 文字通信装置
US6274568B1 (en) * 1998-08-06 2001-08-14 Ronald L. Schnaar Compounds for altering cell surface sialic acids and methods of use therefor
US6762032B1 (en) * 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
EP1326562A1 (de) 2000-10-05 2003-07-16 Seacoast Technologies, Inc. Ausdehnbares gerät zur thermotherapie
US7858602B2 (en) * 2000-10-16 2010-12-28 Rodriguez Victorio C Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells
AU2003282612A1 (en) * 2002-10-11 2004-05-04 The Regents Of The University Of California A method for diagnosis and prognosis of multiple sclerosis
US6947870B2 (en) * 2003-08-18 2005-09-20 Baker Hughes Incorporated Neural network model for electric submersible pump system
FI20155280A (fi) 2015-04-15 2016-10-16 Medicortex Finland Oy Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311686A (en) * 1979-04-30 1982-01-19 The Immunology Development Corporation Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis
FR2618439B1 (fr) * 1987-07-21 1990-05-25 Strosberg Arthur Sequences d'amino-acides reproduisant au moins en partie la sequence des lectines animales et humaines, leurs procedes d'obtention, leurs applications diagnostiques et therapeutiques
EP0337799B1 (de) * 1988-04-14 1996-08-07 Incyte Pharmaceuticals, Inc. 14-Beta-gal Sauger-Lectin

Also Published As

Publication number Publication date
JP3032290B2 (ja) 2000-04-10
JPH05500858A (ja) 1993-02-18
IE64042B1 (en) 1995-06-28
AU6421490A (en) 1991-04-08
IE903190A1 (en) 1991-03-13
ES2057476T3 (es) 1994-10-16
ATE90791T1 (de) 1993-07-15
EP0416984B1 (de) 1993-06-16
AU648516B2 (en) 1994-04-28
FI921009A0 (fi) 1992-03-06
DE69001972D1 (de) 1993-07-22
EP0416984A1 (de) 1991-03-13
WO1991003737A1 (fr) 1991-03-21
CA2024731A1 (fr) 1991-03-07
DE69001972T2 (de) 1993-09-23
FR2651581A1 (fr) 1991-03-08
US5225352A (en) 1993-07-06
DK0416984T3 (da) 1993-08-16
NO920852D0 (no) 1992-03-04
FR2651581B1 (fr) 1994-05-13

Similar Documents

Publication Publication Date Title
NO920852L (no) Midler for diagnostisering av demyelinisante neuropatier,saerlig multippel sklerose
ES2036737T3 (es) Procedimiento para la obtencion de mezclas farmaceuticas.
DE3880047D1 (de) Zusammensetzung eines zusatzes.
PT73161B (fr) Procede pour la preparation de derives de n-(vynblastinoyl-23) aux amino-acides et peptides et son application terapeutique
NO904291D0 (no) Fremgangsmaate for fremstilling av radiomerkede antikoagulerende peptider.
SE8104016L (sv) Framstellning av limulus-lysat
ES534098A0 (es) Procedimiento para la obtencion de eglinas b o c modificadas
DE59001418D1 (de) Antikoagulanz enthaltendes mittel.
ES519944A0 (es) Procedimiento para la preparacion de proteinas succiniladas que contienen hierro.
ATE207205T1 (de) Verfahren zumm assay von endotoxin-konzentration
IL93207A0 (en) A monoclonal antibody which binds to factor betaxiia and shows no substantial binding to factor xii
NO880307D0 (no) Fremgangsmaate for fremstilling av aminoharpiksbindemiddel.
NO903474D0 (no) Fremgangsmaate for fremstilling av neoalkyltrioltriestere.
NO904292D0 (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
EP0109434A4 (de) In vitro diagnoseverfahren unter verwendung von monoklonalen antikörpern gegen konnektive gewebeproteine.
DE69015372D1 (de) Protein-testverfahren.
LU90380I2 (fr) Tetravac
ES2111757T3 (es) Regiones antigenicas de complejos de particulas liberadas por tumores (tlp) y anticuerpos contra los mismos.
NO894880L (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
DE3570677D1 (en) Acino-foetal differentiation proteins associated with cancer of the pancreas, antiserum and monoclonal antibodies against these proteins and processes for their preparation
ES507180A0 (es) Procedimiento de preparacion de amino alcosi furanos o tio- fenos.
AU560165B2 (en) Chromophoric peptides
ES2148248T3 (es) Peptidos de la lipoproteina (a) y su utilizacion.
ES494256A0 (es) Procedimiento de preparacion de (20 s) - 3 - - ((aminoace- til)amino)-5 - - pregnan- 20 - ol
IT1227005B (it) Test immunoenzimatico competitivo per la determinazione della proteina c reattiva (p.c.r.)